AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
MetLife Price Target Lowered to $98 by Morgan Stanley
ByAinvest
Tuesday, Jul 15, 2025 7:36 pm ET1min read
Morgan Stanley analyst Bob Huang has lowered MetLife's (MET) price target to $98 from $99 while maintaining an Overweight rating on the shares.
Morgan Stanley analyst Bob Huang has adjusted the price target for MetLife (MET) from $99.00 to $98.00 USD, while maintaining an "Overweight" rating on the shares [1]. This adjustment reflects a slight downward revision in the projected value of MetLife's stock, indicating a 1.01% decrease in the price target.Despite the reduction in the price target, Morgan Stanley's overall outlook on MetLife remains positive, as evidenced by the continued "Overweight" rating. This rating suggests that the analysts expect MetLife's stock to perform better than the market average over the next 12 months.
The latest adjustment follows a series of updates from various analysts. Keefe, Bruyette & Woods, for instance, cut their price target for MetLife from $95.00 to $94.00, also maintaining an "outperform" rating [2]. Wells Fargo & Company raised their target price from $91.00 to $94.00, while Morgan Stanley initially boosted their target from $94.00 to $99.00. JPMorgan Chase & Co. also increased their target from $86.00 to $95.00, and Piper Sandler raised their target from $92.00 to $94.00 [2].
The consensus among analysts is that MetLife's stock is currently undervalued, with the average target price standing at $95.25, implying an upside of 22.37% from the current price of $77.84 [1]. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1 [1].
MetLife's recent earnings report showed strong performance, with earnings per share (EPS) of $1.96 for the quarter, up 15.6% from the same period last year. The company also authorized a share buyback plan, indicating confidence in its stock's valuation [2]. Institutional investors have been increasing their stakes in MetLife, with several major investors boosting their positions in the second quarter [2].
References:
[1] https://www.gurufocus.com/news/2975406/met-morgan-stanley-adjusts-price-target-for-metlife-met-stock-news
[2] https://www.marketbeat.com/instant-alerts/metlife-nysemet-price-target-cut-to-9400-by-analysts-at-keefe-bruyette-woods-2025-07-09/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet